Jan Weiler

2.5k total citations
17 papers, 1.4k citations indexed

About

Jan Weiler is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Jan Weiler has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Jan Weiler's work include RNA Interference and Gene Delivery (10 papers), Advanced biosensing and bioanalysis techniques (10 papers) and MicroRNA in disease regulation (4 papers). Jan Weiler is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Advanced biosensing and bioanalysis techniques (10 papers) and MicroRNA in disease regulation (4 papers). Jan Weiler collaborates with scholars based in Switzerland, United States and Germany. Jan Weiler's co-authors include Jonathan Hall, Johannes C. Hunziker, François Natt, Dylan Morrissey, Joerg Lange, Xavier C. Ding, Dalia Cohen, Helge Großhans, Shanthi Ganesh and Mansoor M. Amiji and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Nature Biotechnology.

In The Last Decade

Jan Weiler

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Weiler Switzerland	13	1.2k	638	91	67	59	17	1.4k
Donald D. Rao United States	15	803 0.7×	243 0.4×	156 1.7×	118 1.8×	49 0.8×	22	1.1k
Ryan L. Setten United States	8	1.1k 0.9×	284 0.4×	105 1.2×	89 1.3×	110 1.9×	10	1.3k
Marianne Bénard France	16	1.5k 1.2×	344 0.5×	64 0.7×	38 0.6×	82 1.4×	22	1.6k
Anna Git United Kingdom	19	1.4k 1.1×	865 1.4×	112 1.2×	84 1.3×	48 0.8×	25	1.7k
Rajendra K. Pandey United States	14	1.3k 1.0×	316 0.5×	140 1.5×	32 0.5×	66 1.1×	22	1.6k
Martin M. Fabani United Kingdom	12	1.2k 1.0×	525 0.8×	234 2.6×	44 0.7×	29 0.5×	17	1.5k
Mark Y. Fang United States	8	2.1k 1.7×	306 0.5×	116 1.3×	47 0.7×	42 0.7×	10	2.3k
Katrin Tiemann United States	11	702 0.6×	183 0.3×	108 1.2×	81 1.2×	64 1.1×	15	845
Marcela Dávila López Sweden	15	924 0.8×	190 0.3×	97 1.1×	80 1.2×	46 0.8×	36	1.1k
Jennifer A. Lockridge United States	10	1.5k 1.2×	389 0.6×	225 2.5×	46 0.7×	78 1.3×	12	1.7k

Countries citing papers authored by Jan Weiler

Since Specialization

Citations

This map shows the geographic impact of Jan Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Weiler more than expected).

Fields of papers citing papers by Jan Weiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Weiler. The network helps show where Jan Weiler may publish in the future.

Co-authorship network of co-authors of Jan Weiler

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Weiler. A scholar is included among the top collaborators of Jan Weiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Weiler. Jan Weiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Maris, Christophe, Sebastian König, Maxim Yulikov, et al.. (2018). Structural basis of si RNA recognition by TRBP double‐stranded RNA binding domains. The EMBO Journal. 37(6). 42 indexed citations

Ganesh, Shanthi, Arun K. Iyer, Jan Weiler, Dylan Morrissey, & Mansoor M. Amiji. (2013). Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer. Molecular Therapy — Nucleic Acids. 2. e110–e110. 115 indexed citations

Stalder, Lukas, Wolf Heusermann, Lena Sokol, et al.. (2013). The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing. The EMBO Journal. 32(8). 1115–1127. 171 indexed citations

Weiler, Jan, et al.. (2010). Improving gene silencing of siRNAs via tricyclo-DNA modification. PubMed. 1(1). 9–16. 12 indexed citations

Ding, Xavier C., Jan Weiler, & Helge Großhans. (2008). Regulating the regulators: mechanisms controlling the maturation of microRNAs. Trends in biotechnology. 27(1). 27–36. 71 indexed citations

Beuvink, Iwan, Fabrice A. Kolb, Wolfgang Budach, et al.. (2007). A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Research. 35(7). e52–e52. 131 indexed citations

Huesken, Dieter, Joerg Lange, Craig Mickanin, et al.. (2006). Correction: Corrigendum: Design of a genome-wide siRNA library using an artificial neural network. Nature Biotechnology. 24(8). 1033–1033. 1 indexed citations

Weiler, Jan, Johannes C. Hunziker, & Jonathan Hall. (2005). Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?. Gene Therapy. 13(6). 496–502. 302 indexed citations

Huesken, Dieter, Joerg Lange, Craig Mickanin, et al.. (2005). Design of a genome-wide siRNA library using an artificial neural network. Nature Biotechnology. 23(8). 995–1001. 291 indexed citations

10.

Ruetz, Stephan, François Natt, Jonathan Hall, et al.. (2004). The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels. Experimental Cell Research. 303(2). 482–493. 22 indexed citations

11.

Natt, François, et al.. (2003). Linear Polyethylenimine as a Tool for Comparative Studies of Antisense and Short Double-Stranded RNA Oligonucleotides. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1729–1731. 19 indexed citations

12.

Hall, Jonathan, Dieter Hüsken, Pierre Martin, et al.. (2003). A Role for Oligonucleotide-Based RNA-Knock Down Technologies in Functional Genomics. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 641–644. 5 indexed citations

13.

Kinzel, Bernd, Jonathan Hall, François Natt, Jan Weiler, & Dalia Cohen. (2002). Downregulation of Hus1 by antisense oligonucleotides enhances the sensitivity of human lung carcinoma cells to cisplatin. Cancer. 94(6). 1808–1814. 17 indexed citations

14.

Natt, François, et al.. (2001). Specific Inhibition of the Rat Ligand-Gated Ion Channel P ₂ X ₃ Function Via Methoxyethoxy-Modified Phosphorothioated Antisense Oligonucleotides. Antisense and Nucleic Acid Drug Development. 11(3). 165–174. 20 indexed citations

15.

Hüsken, Dieter, et al.. (2001). NEW APPROACHES TOWARDS FLUORESCENCE LABELLING OF MESSENGER RNA TRANSCRIPTS. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1181–1185. 5 indexed citations

16.

Weiler, Jan. (1997). Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays. Nucleic Acids Research. 25(14). 2792–2799. 171 indexed citations

17.

Weiler, Jan, et al.. (1997). Designs and solutions to multiple trait comparisons. Animal Biotechnology. 8(1). 107–122. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact